[Heroic] Company Files IND Application with Taiwan TFDA for B10 L-BPA Injection for Pre-operative Adjuvant Therapy in Locally Advanced Oral Cancer
NQ Score
0/100
N1 Content Completeness
0
AI Summary (NQ-processed)
Heroic has submitted an Investigational New Drug (IND) application to Taiwan's TFDA for its B10 L-BPA injection, aimed at pre-operative adjuvant therapy for locally advanced oral cancer. This study will evaluate Boron Neutron Capture Therapy (BNCT) as a novel treatment strategy.